Top

Published in:

Open Access 01-12-2023 | Research

Expression signature and prognostic value of CREC gene family in human colorectal cancer

Authors: Junya Ning, Min Liu, Jing Shen, Deping Wang, Lijuan Gao, Huiyu Li, Jimin Cao

Published in: BMC Cancer | Issue 1/2023

Abstract

Colorectal cancer (CRC) is one of the malignant tumors with the highest morbidity and mortality and poor prognosis. The mammalian gene family of Cab45/reticulocalbin/ERC-45/calumenin (CREC) consists of RCN1, RCN2, RCN3, SDF4 and CALU. Although CREC family members have been associated with CRC, the expression pattern, prognostic value, and the role of CREC family in CRC remain unclear. In this study, the expression, survival and biological functions of CREC family in CRC were determined via bioinformatic datasets analysis and experimental verification on clinical CRC specimen. Bioinformatic analysis showed that the expression levels of most CREC family genes were higher in CRC tissues than in normal colorectal tissues. The qPCR and western blot results also revealed that the transcriptional and protein levels of CREC family were elevated in CRC tissues compared with adjacent tissues. Besides, CREC family was significantly correlated with advanced tumor stage and poor prognosis of CRC patients. The expression levels of CREC family had correlations with genomic mutation and methylation, and with the infiltration levels of CD4 + T cells, macrophages, neutrophils, and dendritic cells in the microenvironment of CRC. Functional networks enrichment analysis indicated that the genes of CREC family were essential factors for CRC metastasis. Collectively, these findings suggest that CREC family might be potential targets for the treatment of CRC and candidate prognostic markers for CRC patients.

Available only for authorised users

Hossain MS, Karuniawati H, Jairoun AA, et al. Colorectal Cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14:1732.

Das V, Kalita J, Pal M. Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges. Biomed Pharmacother. 2017;87:8–19.PubMed

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed

Honore B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. BioEssays. 2009;31:262–77.PubMed

Suzuki N, Ban S, Itoh E, et al. Calcium-dependent structural changes in human reticulocalbin-1. J Biochem. 2014;155:281–93.PubMed

Shen J, Zhou T, Li H, et al. Cab45s inhibits neuronal apoptosis following intracerebral hemorrhage in adult rats. Brain Res Bull. 2018;143:36–44.PubMed

Uzozie AC, Selevsek N, Wahlander A, et al. Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis. Mol Cell Proteomics. 2017;16:407–27.PubMedPubMedCentral

Mikula M, Rubel T, Karczmarski J, et al. Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics. 2011;11:215–24.PubMed

Chen X, Shao W, Huang H, et al. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer. Hum Pathol. 2019;83:140–8.PubMed

10.

Du Y, Miao W, Jiang X, et al. The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis. Front Oncol. 2021;11:683951.PubMedPubMedCentral

11.

Yang Y, Wang J, Xu S, et al. Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma. Transl Neurosci. 2021;12:67–75.PubMedPubMedCentral

12.

Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6:1–6.PubMedPubMedCentral

13.

Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–60.PubMedPubMedCentral

14.

Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27.PubMedPubMedCentral

15.

Lánczky A, Győrffy B. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021;23:e27633.PubMedPubMedCentral

16.

Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:eaan2507.

17.

Lambert SA, Jolma A, Campitelli LF, et al. The Human Transcription Factors. Cell. 2018;172:650–65.PubMed

18.

Zhang Q, Liu W, Zhang HM, et al. hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020;18:120–8.PubMedPubMedCentral

19.

Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92-7.PubMed

20.

Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.

21.

Li T, Fan J, Wang B, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77:e108–10.PubMedPubMedCentral

22.

Wang Z, Jensen MA, Zenklusen JC. A practical guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol. 2016;1418:111–41.PubMed

23.

Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.PubMedPubMedCentral

24.

Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52.PubMed

25.

Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.PubMedPubMedCentral

26.

The Gene Ontology C. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330–8.

27.

Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353–61.PubMed

28.

Skrzypczak M, Goryca K, Rubel T, et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 2010;5:e13091.

29.

Sabates-Bellver J, Van der Flier LG, de Palo M, et al. Transcriptome profile of human colorectal adenomas. Mol Cancer Res. 2007;5:1263–75.PubMed

30.

Ming S, Gao J. Sun T [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells]. Zhongguo Fei Ai Za Zhi. 2010;13:464–9.PubMed

31.

Ding J, Meng Y, Han Z, et al. Pan-cancer analysis of the oncogenic and immunological role of RCN3: A potential biomarker for prognosis and immunotherapy. Front Oncol. 2022;12:811567.PubMedPubMedCentral

32.

Feng Z, Yu Q, Zhang T, et al. Updates on mechanistic insights and targeting of tumour metastasis. J Cell Mol Med. 2020;24:2076–86.PubMedPubMedCentral

33.

Su R, Wu X, Tao L, et al. The role of epigenetic modifications in Colorectal Cancer Metastasis. Clin Exp Metastasis. 2022;39:521-539.

34.

Sajjanar B, Trakooljul N, Wimmers K, et al. DNA methylation analysis of porcine mammary epithelial cells reveals differentially methylated loci associated with immune response against Escherichia coli challenge. BMC Genomics. 2019;20:623.PubMedPubMedCentral

35.

Liu X, Zhang N, Wang D, et al. Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells. Cancer Sci. 2018;109:1147–57.PubMedPubMedCentral

36.

Gu J, Liu Y, Qi T, et al. Long non-coding RNA DUXAP8 elevates RCN2 expression and facilitates cell malignant behaviors and angiogenesis in cervical cancer via sponging miR-1297. Diagn Pathol. 2021;16:105.PubMedPubMedCentral

37.

Ding D, Huang H, Jiang W, et al. Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway. Oncogene. 2017;36:6691–700.PubMed

38.

Ramirez-Torres A, Gil J, Contreras S, et al. Quantitative proteomic analysis of cervical cancer tissues identifies proteins associated with cancer progression. Cancer Genomics Proteomics. 2022;19:241–58.PubMedPubMedCentral

39.

Luo J, Li Z, Zhu H, et al. A novel role of Cab45-G in mediating cell migration in cancer cells. Int J Biol Sci. 2016;12:677–87.PubMedPubMedCentral

40.

Chen L, Xu S, Xu Y, et al. Cab45S promotes cell proliferation through SERCA2b inhibition and Ca2+ signaling. Oncogene. 2016;35:35–46.PubMed

41.

Ludvigsen M, Thorlacius-Ussing L, Vorum H, et al. Proteomic Characterization of colorectal cancer cells versus normal-derived colon mucosa cells: approaching identification of novel diagnostic protein biomarkers in colorectal cancer. Int J Mol Sci. 2020;21:3466.

42.

Zheng P, Wang Q, Teng J, et al. Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology. Pharmacol Res. 2015;99:11–5.PubMed

43.

Zhang H, Zhao X, Wang J, et al. Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer. Front Oncol. 2021;11:683915.PubMedPubMedCentral

44.

Fu H, Chen R, Wang Y, et al. Reticulocalbin 1 is required for proliferation and migration of non-small cell lung cancer cells regulated by osteoblast-conditioned medium. J Cell Mol Med. 2021;25:11198–211.PubMedPubMedCentral

45.

Gomez J, Areeb Z, Stuart SF, et al. EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism. Cancers (Basel). 2021;13:1198.

46.

Lu W, Chen H, Liang B, et al. Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme. Front Mol Biosci. 2021;8:736947.PubMedPubMedCentral

47.

Mei C, Jiang X, Gu Y, et al. YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling. Am J Cancer Res. 2021;11:2238–51.PubMedPubMedCentral

48.

Wang G, Zhou J, Lu F, et al. Downregulation of microRNA1835p inhibits the proliferation and invasion of colorectal cancer cells by inactivating the reticulocalbin2/Wnt/betacatenin signaling pathway. Mol Med Rep. 2019;19:4475–83.PubMed

49.

Wang G, Wang Q, Fan Y, et al. Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer. Am J Cancer Res. 2017;7:2169–79.PubMedPubMedCentral

50.

Zhou Y, Bian S, Zhou X, et al. Single-cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal cancer. Cancer Cell. 2020;38:818-28 e5.PubMed

51.

Blank B, von Blume J. Cab45-Unraveling key features of a novel secretory cargo sorter at the trans-Golgi network. Eur J Cell Biol. 2017;96:383–90.PubMed

52.

Tang H, Ma M, Dai J, et al. miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy. J Exp Clin Cancer Res. 2019;38:212.PubMedPubMedCentral

53.

Nagano K, Imai S, Zhao X, et al. Identification and evaluation of metastasis-related proteins, oxysterol binding protein-like 5 and calumenin, in lung tumors. Int J Oncol. 2015;47:195–203.PubMed

54.

Roger E, Martel S, Bertrand-Chapel A, et al. Schwann cells support oncogenic potential of pancreatic cancer cells through TGFbeta signaling. Cell Death Dis. 2019;10:886.PubMedPubMedCentral

55.

Ke MY, Xu T, Fang Y, et al. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation. Cancer Lett. 2021;513:14–25.PubMed

56.

Pan Y, Yu Y, Wang X, et al. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.PubMedPubMedCentral

Title: Expression signature and prognostic value of CREC gene family in human colorectal cancer
Authors: Junya Ning
Min Liu
Jing Shen
Deping Wang
Lijuan Gao
Huiyu Li
Jimin Cao
Publication date: 01-12-2023
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-023-11303-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint

Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland？

Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)

Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study

Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer